These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 10419606)
1. The risk of cystic fibrosis with prenatally detected echogenic bowel in an ethnically and racially diverse North American population. Monaghan KG; Feldman GL Prenat Diagn; 1999 Jul; 19(7):604-9. PubMed ID: 10419606 [TBL] [Abstract][Full Text] [Related]
2. Is testing for cytomegalovirus and cystic fibrosis indicated in members of a nonwhite pregnant population in whom the fetus has an echogenic bowel? Aboujaoude R; Alvarez J; Ganesh V; Apuzzio J Am J Perinatol; 2006 Jul; 23(5):319-23. PubMed ID: 16799919 [TBL] [Abstract][Full Text] [Related]
3. Predicting the risk of cystic fibrosis with echogenic fetal bowel and one cystic fibrosis mutation. Bosco AF; Norton ME; Lieberman E Obstet Gynecol; 1999 Dec; 94(6):1020-3. PubMed ID: 10576193 [TBL] [Abstract][Full Text] [Related]
4. The clinical significance of fetal echogenic bowel. Al-Kouatly HB; Chasen ST; Streltzoff J; Chervenak FA Am J Obstet Gynecol; 2001 Nov; 185(5):1035-8. PubMed ID: 11717628 [TBL] [Abstract][Full Text] [Related]
5. Cystic fibrosis and chromosome abnormalities associated with echogenic fetal bowel. Berlin BM; Norton ME; Sugarman EA; Tsipis JE; Allitto BA Obstet Gynecol; 1999 Jul; 94(1):135-8. PubMed ID: 10389734 [TBL] [Abstract][Full Text] [Related]
6. Incidence and Carrier Frequency of CFTR Gene Mutations in Pregnancies With Echogenic Bowel in Nova Scotia and Prince Edward Island. Miller ME; Allen VM; Brock JK J Obstet Gynaecol Can; 2018 Jul; 40(7):896-902. PubMed ID: 29503250 [TBL] [Abstract][Full Text] [Related]
7. Predicting the risk of cystic fibrosis with abnormal ultrasound signs of fetal bowel: results of a French molecular collaborative study based on 641 prospective cases. Muller F; Simon-Bouy B; Girodon E; Monnier N; Malinge MC; Serre JL; Am J Med Genet; 2002 Jun; 110(2):109-15. PubMed ID: 12116247 [TBL] [Abstract][Full Text] [Related]
8. Fetal echogenic bowel and a dilated loop of bowel associated with cystic fibrosis (CF) mutations delta F508 and 2183AA-->G. Rush PW; Vats S; Allitto BA; Qureshi F; Feldman GL Prenat Diagn; 1998 Jun; 18(6):638-40. PubMed ID: 9664617 [No Abstract] [Full Text] [Related]
9. Society for Maternal-Fetal Medicine Consult Series #57: Evaluation and management of isolated soft ultrasound markers for aneuploidy in the second trimester: (Replaces Consults #10, Single umbilical artery, October 2010; #16, Isolated echogenic bowel diagnosed on second-trimester ultrasound, August 2011; #17, Evaluation and management of isolated renal pelviectasis on second-trimester ultrasound, December 2011; #25, Isolated fetal choroid plexus cysts, April 2013; #27, Isolated echogenic intracardiac focus, August 2013). ; Prabhu M; Kuller JA; Biggio JR Am J Obstet Gynecol; 2021 Oct; 225(4):B2-B15. PubMed ID: 34171388 [TBL] [Abstract][Full Text] [Related]
10. Calculating posterior cystic fibrosis risk with echogenic bowel and one characterized cystic fibrosis mutation: avoiding pitfalls in the risk calculations. Hodge SE; Lebo RV; Yesley AR; Cheney SM; Angle H; Milunsky J Am J Med Genet; 1999 Feb; 82(4):329-35. PubMed ID: 10051167 [TBL] [Abstract][Full Text] [Related]
12. Clinical sensitivity of prenatal screening for cystic fibrosis via CFTR carrier testing in a United States panethnic population. Palomaki GE; FitzSimmons SC; Haddow JE Genet Med; 2004; 6(5):405-14. PubMed ID: 15371905 [TBL] [Abstract][Full Text] [Related]